Related Experiment Video
Updated: Jul 24, 2025

Author Spotlight: Illuminating New Avenues for Adipose Tissue Metabolism and Disease Prevention
Published on: October 6, 2023
Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism
Jiwoo Lee1,2, Thomas Gilliland1,2, Satoshi Koyama1
1Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA.
Insights
This study reveals overlapping metabolomic profiles in arterial and venous cardiovascular diseases. Remnant cholesterol plays a key role in arterial diseases like coronary artery disease and peripheral artery disease, but not venous thromboembolism.
Area of Science:
- Cardiovascular Science
- Metabolomics
- Genetics
Background:
- Arterial and venous cardiovascular diseases share genetic correlations, suggesting common underlying mechanisms.
- Understanding distinct and overlapping pathways in coronary artery disease (CAD), peripheral artery disease (PAD), and venous thromboembolism (VTE) is crucial for novel therapeutic targets.
Approach:
- Utilized UK Biobank metabolomic data from 95,402 individuals to assess epidemiologic associations between 249 metabolites and incident CAD, PAD, and VTE.
- Employed bidirectional two-sample Mendelian randomization (MR) and multivariable MR (MVMR) to investigate causal genetic relationships between metabolites and these cardiovascular conditions.
Key Points:
- 194, 111, and 69 metabolites showed epidemiologic links to CAD, PAD, and VTE, respectively, with varying degrees of overlap between disease pairs.
- MR identified 28 metabolites associated with increased risk for both CAD and PAD, and 2 for CAD but decreased risk for VTE.
- MVMR highlighted shared causal effects of metabolites, particularly remnant cholesterol in very-low-density lipoprotein particles, on CAD and PAD.
Conclusions:
- Overlapping metabolomic profiles exist between arterial and venous cardiovascular diseases.
- Remnant cholesterol is implicated as a causal factor in arterial diseases (CAD, PAD) but not in venous thromboembolism.
- Metabolomic profiling and MR provide insights into shared and distinct etiological pathways for cardiovascular diseases.
Rationale:
Arterial and venous cardiovascular conditions, such as coronary artery disease (CAD), peripheral artery disease (PAD), and venous thromboembolism (VTE), are genetically correlated. Interrogating distinct and overlapping mechanisms may shed new light on disease mechanisms.
Objective:
In this study, we aimed to: identify and compare (1) epidemiologic and (2) causal, genetic relationships between metabolites and CAD, PAD, and VTE.
Methods:
We used metabolomic data from 95,402 individuals in the UK Biobank, excluding individuals with prevalent cardiovascular disease. Logistic regression models adjusted for age, sex, genotyping array, first five principal components of ancestry, and statin use estimated the epidemiologic associations of 249 metabolites with incident CAD, PAD, or VTE. Bidirectional two-sample Mendelian randomization (MR) estimated the causal effects between metabolites and cardiovascular phenotypes using genome-wide association summary statistics for metabolites (N = 118,466 from UK Biobank), CAD (N = 184,305 from CARDIoGRAMplusC4D 2015), PAD (N = 243,060 from Million Veterans Project) and VTE (N = 650,119 from Million Veterans Project). Multivariable MR (MVMR) was performed in subsequent analyses.
Results:
We found that 194, 111, and 69 metabolites were epidemiologically associated (P < 0.001) with CAD, PAD, and VTE, respectively. Metabolomic profiles exhibited variable similarity between disease pairs: CAD and PAD (N = 100 shared associations, R2 = 0.499), CAD and VTE (N = 68, R2 = 0.455), and PAD and VTE (N = 54, R2 = 0.752). MR revealed 28 metabolites that increased risk for both CAD and PAD and 2 metabolites that increased risk for CAD but decreased risk for VTE. Despite strong epidemiologic overlap, no metabolites had a shared genetic relationship between PAD and VTE. MVMR revealed several metabolites with shared causal effects on CAD and PAD related to cholesterol content within very-low-density lipoprotein particles.
Conclusions:
While common arterial and venous conditions are associated with overlapping metabolomic profiles, MR prioritized the role of remnant cholesterol in arterial diseases but not venous thrombosis.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Coronary Syndrome III: Diagnostic Studies
Venous Thrombosis I: Introduction
Imaging Studies for Cardiovascular System V: CT

